ZA935055B - Composition and method of treating hepatitis b - Google Patents

Composition and method of treating hepatitis b

Info

Publication number
ZA935055B
ZA935055B ZA935055A ZA935055A ZA935055B ZA 935055 B ZA935055 B ZA 935055B ZA 935055 A ZA935055 A ZA 935055A ZA 935055 A ZA935055 A ZA 935055A ZA 935055 B ZA935055 B ZA 935055B
Authority
ZA
South Africa
Prior art keywords
composition
treating hepatitis
hepatitis
treating
Prior art date
Application number
ZA935055A
Inventor
Kenneth E Sherman
Original Assignee
Us Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Army filed Critical Us Army
Publication of ZA935055B publication Critical patent/ZA935055B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA935055A 1992-07-13 1993-07-13 Composition and method of treating hepatitis b ZA935055B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91467392A 1992-07-13 1992-07-13

Publications (1)

Publication Number Publication Date
ZA935055B true ZA935055B (en) 1995-04-13

Family

ID=25434648

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935055A ZA935055B (en) 1992-07-13 1993-07-13 Composition and method of treating hepatitis b

Country Status (6)

Country Link
EP (1) EP0627930A4 (en)
CN (1) CN1087829A (en)
AU (1) AU4671193A (en)
MX (1) MX9304209A (en)
WO (1) WO1994001125A1 (en)
ZA (1) ZA935055B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
DK0731710T3 (en) * 1993-11-05 2003-06-16 Sciclone Pharmaceuticals Inc Method and preparation for the treatment of patients with compensated liver disease
US6199073B1 (en) 1997-04-21 2001-03-06 Ricoh Company, Ltd. Automatic archiving of documents during their transfer between a peripheral device and a processing device
US5939423A (en) * 1997-04-16 1999-08-17 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir
US6288033B1 (en) 1998-09-25 2001-09-11 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir
EP2427213B1 (en) 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
DK2583680T1 (en) 2011-10-21 2015-01-19 Abbvie Inc Mono (PSI-7977), or combination treatment of DAA for use in the treatment of HCV
CN104383541A (en) 2011-10-21 2015-03-04 艾伯维公司 Methods for treating HCV comprising at least two direct acting antiviral agent, ribavirin but not interferon
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
CN103494769B (en) * 2013-10-08 2015-12-23 深圳翰宇药业股份有限公司 A kind of compound long-acting in-situ gel injection agent for the treatment of chronic viral hepatitis B and preparation method thereof
CA3022119A1 (en) 2016-04-28 2017-11-02 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
CN111450240A (en) * 2020-04-27 2020-07-28 浙江大学 Application of combination of small molecule compound M L N4924 and IFN α in anti-HBV

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8802173D0 (en) * 1988-06-10 1988-06-10 Astra Ab PYRIMIDINE DERIVATIVES
TW224053B (en) * 1991-09-13 1994-05-21 Paul B Chretien
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function

Also Published As

Publication number Publication date
WO1994001125A1 (en) 1994-01-20
AU4671193A (en) 1994-01-31
EP0627930A4 (en) 1997-08-20
CN1087829A (en) 1994-06-15
MX9304209A (en) 1994-04-29
EP0627930A1 (en) 1994-12-14

Similar Documents

Publication Publication Date Title
AP9300598A0 (en) Compositions and method for waste treatment
ZA935055B (en) Composition and method of treating hepatitis b
SG47788A1 (en) Coating composition and method of forming
IL104940A0 (en) Method and composition for the treatment of osteoporosis
PL300549A1 (en) Structural component and method of making same
ZA948252B (en) Method and composition for treatment of autoimmune hepatitis
GB9014307D0 (en) Method of treatment and compositions therefor
PL301204A1 (en) Method of obtaining avermectines and invermectines
PL298446A1 (en) Method of treating fatty substances
EP0472595A4 (en) Method of treatment of hepatitis
PL306093A1 (en) Cataract treating agent and method of obtaining same
GB9224295D0 (en) Method and composition
EP0472663A4 (en) Method of treatment of hepatitis
EP0454169A3 (en) Photomask and method of treating the same
GB9202196D0 (en) Method of treatment
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
GB9226993D0 (en) Method of simultaneous milling and drying
GB2221698B (en) Composition and method of metal surface treatment
AU5467198A (en) Composition and method of treating hepatitis B
SG54220A1 (en) Composition and process for treating metal
AU4652393A (en) Plant treating composition and methods of making and using same
GB9201391D0 (en) Method of treatment
PL289358A1 (en) Posticide and method of treating soil therewith
ZA935113B (en) Lock and method of using same
SG66305A1 (en) Composition and method for treatment of phoshated surfaces